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Abstract
Soluble human leukocyte antigen-G (HLA-G) is a non-classical class Ib HLA molecule that is secreted from blastocysts.
Soluble HLA-G modulates the immune tolerance of the mother and can be used as a prognostic factor for the clinical
pregnancy rate. However, the underlying mechanism of how soluble HLA-G5 affects pregnancy remains largely unknown.
We hypothesized that soluble HLA-G5 promotes successful implantation and pregnancy by modulating trophoblast
invasion through receptor binding and activation of extracellular signal-regulated protein kinase (ERK) signaling pathway.
Recombinant HLA-G5 protein over-expressed in E. coli BL21 was purified to near homogeneity. We studied the expression of
HLA-G5 and its receptors, the leukocyte immunoglobulin-like receptor subfamily B1 (LILRB1) and killer cell immunoglobulin-
like receptor 2DL4 (KIR2DL4), in primary trophoblasts and trophoblastic (JAr and JEG-3) cell lines by florescence-labeled
HLA-G5. HLA-G5 was detected in the primary trophoblasts and JEG-3 cells. The LILRB1 and KIR2DL4 receptors were
expressed in both primary trophoblasts and trophoblastic cell lines. HLA-G5 stimulated cell invasion (p,0.05) and increased
urokinase (uPA) and matrix metalloproteinases (MMPs) transcripts and their activity (p,0.05) in trophoblastic cells. HLA-G5
activated the ERK signaling pathway and induced ERK1/2 phosphorylation in the trophoblastic cell lines. Addition of ERK
inhibitors (U0126 and PD98059) nullified the stimulatory effect of HLA-G5 on trophoblastic cell invasion. Taken together,
HLA-G5 induced trophoblast invasion by binding to KIR2DL4 and LILRB1, by increasing uPA and MMPs expressions and by
activating the ERK signaling pathway.
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Introduction
Trophoblast invasion plays an important role in embryo
implantation and placentation. During implantation, the inva-
sive trophoblast interacts with maternal decidual cells enabling
the formation of the spiral arteries that supply the fetus during
its development [1]. Although the trophoblast is semi-allogeneic
and should elicit a maternal immune response [2], it does not
express the classical human leucocyte antigen (HLA) class Ia
and II, but rather the non-classical HLA class Ib molecules that
confers maternal immunotolerance to the cells during pregnan-
cy [3–6].
Among the unique HLA class Ib members, HLA-G was the first
to be isolated from human extra-villous trophoblastic cell
membranes [7]. HLA-G is thought to protect the trophoblast
from attack by the decidual natural killer (NK) cells, macrophages
and cytotoxic T cells by binding to their receptors such as the
leukocyte immunoglobulin-like receptor subfamily B1 (LILRB1)
and the killer cell immunoglobulin-like receptor 2DL4 (KIR2DL4)
[8]. HLA-G triggers cytokine secretion, including interleukin (IL)-
10, tumor necrosis factor (TNF)-a and interferon (IFN)-c from
decidual leukocytes, which contributes to placental remodeling [9].
HLA-G also inhibits cytotoxicity leading to apoptosis of the
decidual leukocytes in pregnancy complications [5,10–11].
Seven HLA-G isoforms can be generated from the alternative
splicing of the HLA-G mRNA [12–13]. Four of the isoforms are
membrane-bound (HLA-G1, G2, G3 and G4) and three of them
are secretory (soluble HLA-G5, G6 and G7) [14]. The full-length
soluble HLA-G5 has three domains, namely a1, a2 and a3,
whereas HLA-G6 lacks the a2 domain and HLA-G7 lacks a2 and
a3 domains [15]. The structure of HLA-G5 is similar to the
classical HLA Class I molecules and can bind to the decidual
leukocytes [16]. HLA-G5 is well known for its role in immune
tolerance, whether it has a direct effect on trophoblast function
remains unclear.
We hypothesized that HLA-G5 regulates trophoblast inva-
sion, which in turn modulates embryo implantation and
placentation. In this study we produced and characterized
the HLA-G5 recombinant protein and studied the role of the
HLA-G5 protein in trophoblast invasion. We examined the
receptor(s) and mechanism(s) mediating the biological effects of
HLA-G5.
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Materials and Methods
Ethics Statement
The protocol in this study was approved by The Institutional
Review Board of the University of Hong Kong/Hospital Authority
Hong Kong West Cluster. Written consent was obtained from
women before undergoing surgical termination of pregnancy and
collection of placental villi samples for research.
Recombinant HLA-G5 expression
HLA-G5 complementary DNA was prepared by reverse
transcription of total RNA of the human choriocarcinoma JEG-
3 cells expressing HLA-G protein [17]. Briefly, total RNA was
purified using the QuickPrep RNA extraction kit (GE Healthcare,
Salt Lake City, UT, USA) and reverse transcribed with the
TaqMan reverse transcription reagent kit (Applied Biosystems,
Foster City, CA, USA). The cDNA was then amplified using PCR
with HLA-G5 primers, G5_F: 59-ggaattccatATGGTGGT-
CATGGCACCCCGAACCCTCTTC-39 and G5_R: 59-
cgcggatccTTAAAGGTCTTCAGAGAGGCTCCTGCTTTCC-
39 (the restriction sites used for cloning are underlined). The PCR
conditions were 95uC for 5 minutes, 35 cycles at 95uC for 30
seconds, 57uC for 30 seconds, 72uC for 1 minute, followed by
72uC for 7 minutes. The PCR amplicon was digested with BamHI
and NdeI and cloned into a pET-15b vector (Novagen, Darmstadt,
Germany). The recombinant plasmid was transformed into E. coli
BL21 (Novagen) for the expression studies. The E. coli were treated
with 0.5 mM isopropyl-b-D-thiogalactoside at 30uC for 3 hours to
over-express the recombinant HLA-G5 protein. The expressed
proteins were sequestered in the inclusion bodies of E. coli, and
were extracted and purified using the Protein Refolding kit
(Novagen). The purified protein was dialyzed in renaturing buffer
(20 mM Tris-HCl, pH 8.5, with 1 mM reduced glutathione and
0.2 mM oxidized glutathione) and insoluble proteins were
removed by a 0.22 mm filter. Bacterial endotoxin, which is known
to induce cytokine secretion from animal cells, was removed using
the Detoxi-GelTM Endotoxin Removing Gel (Thermo Fisher
Scientific Inc., Rockford, USA). The recombinant HLA-G5
protein was confirmed by Western blotting using the 5A6G7
antibody (Abcam, Cambridge, MA, USA) and by tandem mass
spectrometry (MS/MS, Proteomic Laboratory for System Biology
Research, HK).
Trophoblastic cell lines and cell culture
Human choriocarcinoma JAr and JEG-3 cell lines (ATCC,
Manassas, VA, USA) were cultured in RPMI-1640 and DMEM/
F12 media (Sigma), respectively, supplemented with 10% heat-
inactivated fetal bovine serum, 1% glutamic acid and 1%
penicillin/streptomycin. The cells were cultured at 37uC in air
with 5% CO2.
Isolation of human primary trophoblasts
Placental villi samples were obtained from women undergoing
surgical termination of pregnancy in the first trimester. Primary
human trophoblasts were isolated as previously described [18–19].
Briefly, the collected placental villi were minced and digested in
0.25% trypsin for 15 minutes with constant shaking. Single cells
were isolated by filtration through 100 mm and 40 mm filters (BD
Bioscience, Bedford, MA, USA) and centrifuged with Lympho-
prep (GE Healthcare, Uppsala, Sweden) at 710 g for 20 minutes.
Cells were collected and cultured on a fibronectin-coated plate
overnight. The adherent cells were harvested for use in the next
experiments.
Western blotting and immunostaining
The expression of HLA-G5 and receptors in trophoblasts was
analyzed by Western blotting and immunostaining. For Western
blotting, CytobusterTM protein extraction reagent (Merck, Darm-
stadt, Germany) was used for cell lysis. Soluble proteins were
separated by 10% SDS-PAGE and transferred to a PVDF
membrane. Primary antibodies against HLA-G5 (5A6G7, Abcam,
MA, USA), KIR2DL4 (mAb 33, Abcam) and LILRB1 (HP-F1,
Abcam) were used at a dilution of 1:1000. The anti-b-actin
antibody (1:5000) (Sigma) was used as the loading control.
Recombinant HLA-G5 protein was used as the positive control,
and the nature killer cell line (NK92mi) was used as the control for
the detection of KIR2DL4 and LILRB1 proteins.
For the immunostaining assay, cultured cells were fixed in 4%
paraformaldehyde (Sigma) at 4uC for 15 minutes and permeabi-
lized with 0.1% Triton X-100 (Sigma) in blocking solution (3%
donkey serum in PBS) for 20 minutes. The cells were blocked with
3% donkey serum in PBS at room temperature for 1 hour and
then incubated at 4uC overnight with the primary antibodies
(1:1000 in blocking solution) against HLA-G5, KIR2DL4 and
LILRB1. After washing five times with PBST (0.05% Triton X-
100 in PBS), the cells were incubated with Alexa Fluor 488 donkey
anti-mouse IgG antibody (Invitrogen, Carlsbad, CA, USA) for 1
hour, then washed and examined under a fluorescence microscope
(Nikon, Japan).
HLA-G5 Binding assay
Flow cytometry was used to assess the binding of HLA-G5 to
the cells as previously described [20]. Briefly, recombinant HLA-
G5 protein was labeled using the Alexa Fluor 488 microscale
protein labeling kit (Molecular Probes, Carlsbad, CA, USA). Pre-
labeled HLA-G5 protein (1 mg/mL) was incubated with the JAr
and JEG-3 cells (56105 each) for 1 hour. For the antibody
blocking group, pre-labeled HLA-G5 protein was mixed with the
5A6G7 antibody in a molar ratio of 1:5 at room temperature for
half an hour before incubation with the cells. After washing, the
fluorescence signal was detected using a BD FACSCantoII flow
cytometer (BD Bioscience, San Jose, CA, USA) equipped with an
argon laser (488 nm wavelength with a 525 nm band pass filter).
The results were analyzed using the FlowJo software (Tree Star
Inc., Ashland, OR, USA).
Proliferation assay
The proliferation of the JAr and JEG-3 cells were measured
with the fluorometric CyQUANT NF Cell proliferation assay Kit
(Invitrogen) in accordance with the manufacturer’s instructions.
Cells at a density of 6000 cells/well were treated with different
concentrations of HLA-G5 recombinant protein (0, 0.1, 1, 10 mg/
mL) for 24 hours before incubating with the dye binding solution
for 45 minutes. The fluorescence intensity was measured using a
fluorescence microplate reader with excitation at 485 nm and
emission detection at 530 nm. The results were presented as the
percentage of fluorescence intensity relative to the untreated
group.
Migration assay
The CytoSelectTM 96-well Cell Migration Assay Kit (Cell
Biolabs Inc., CA, USA) was used to study the trophoblast
migration. Briefly, 100 mL of the cell suspension was placed in
the upper chamber at a density of 56105 cells/well, and treated
with HLA-G5 (0, 0.1, 1 mg/mL) for 22 hours. The migratory cells
at the bottom of the polycarbonate membrane of the chamber
were dissociated, lysed and then detected using CyQuantH GR
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Dye. The results were presented as the percentage of fluorescence
intensity relative to the untreated group.
Invasion assay
The invasiveness of trophoblasts was measured in a Matrigel
pre-coated invasion chamber (BD BioCoatTM MatrigelTM Inva-
sion Chamber, BD Bioscience) as previously described [21].
Briefly, JAr and JEG-3 cell suspensions were placed in the inserts
at a density of 26105 cells/mL and treated with different
concentrations of HLA-G5 recombinant protein (0, 0.1, 1 mg/
mL) for 24 hours. The primary trophoblasts were seeded at a
density of 56106 cells/mL and were treated with HLA-G5 for 5
days. The invasive cells at the bottom of the chamber membrane
were stained with 0.1% crystal violet (Millipore, Billerica, CA,
USA) and quantified using a fluorescence microplate reader with
excitation at 480 nm and emission at 520 nm. The results were
presented as the percentage of fluorescence intensity relative to the
untreated group.
Expression of urokinase (uPA) and matrix
metalloproteinases (MMPs)
Trophoblast cells were treated with different concentrations of
the HLA-G5 recombinant protein (0, 0.1, 1 mg/mL) for 24 hours.
The cells and the spent culture media were collected. Total RNA
was isolated and used for real-time PCR analysis of uPA (TaqMan
probe: Hs00170182_m1), MMP2 (TaqMan probe:
Hs00901425_m1) and MMP9 (TaqMan probe: Hs00957555_m1)
expressions using an ABI 7500 sequence detector (Applied
Biosystems). The housekeeping 18S rRNA (TaqMan probe:
Hs99999901_s1) was used as the endogenous control. The results
were presented as the threshold cycle (CT) normalized with 18S and
expressed relative to the untreated control. The activities of the
secreted MMP-2 and -9 in the culture media were determined by
gelatin zymography as previously described [22]. In addition, the
activity of uPA was measured using the QIA 125 Urokinase Activity
Assay kit (Calbiochem, La Jolla, CA, USA) in accordance with the
manufacturer’s instructions. Briefly, the collected culture media
were mixed with 50 ml of substrate solution in a 96-well microplate
and incubated at 37uC for 45 minutes. Blank culture medium was
used as the control. The fluorescence intensity was quantified using
a fluorescence plate reader with excitation at 380 nm and emission
at 460 nm. The results were presented as the percentage of
fluorescence intensity relative to blank control.
Analysis of signaling pathways involved in trophoblast
invasion
Trophoblast cells were treated with 1 mg/mL recombinant
HLA-G5 protein for 5, 15 and 30 minutes. Western blotting was
used to detect the expression of mitogen-activated protein kinases
(MAPK), extracellular signal-regulated protein kinases (ERK),
phosphorylated ERK (BD Biosciences) and b-actin using their
primary antibodies at a concentration of 1:1000. The results were
presented as the percentage relative to the untreated control. The
ERK inhibitors U0126 and PD98059 at concentrations of 10 mM
were used to pre-treat the trophoblast for 30 minutes, and the cells
were then incubated with HLA-G5 for 24 hours. The changes in
trophoblast invasion were studied using the invasion chamber
described above.
Figure 1. Expression and purification of HLA-G5 protein from E. coli. (A) Recombinant HLA-G5 protein was purified from E. coli BL21 cells and
stained with Coomassie brilliant blue. HLA-G5 protein was expressed in total bacterial lysate after 3 hours of IPTG induction (Total, 3 hrs). The HLA-G5
protein was further purified from the inclusion bodies (pellet) of the lysate and refolded (refolded HLA-G5) in native dialysis buffer. (B) Western blot
analysis of IPTG induced (0 – 5 hrs) recombinant HLA-G5 protein from the total bacterial lysate probed with His-Tag (Anti-6xHis) and HLA-G5 (5A6G7)
antibodies. (C) The identity of the purified HLA-G5 protein was confirmed by mass spectrometry (MS/MS). The peptide score for the HLA-G5 protein
was 613.
doi:10.1371/journal.pone.0076023.g001
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Figure 2. Expression of HLA-G5 and its receptors LILRB1 and KIR2DL4 in trophoblasts. (A) Western blot analysis of the total cell lysate
showed HLA-G5 was expressed in human choriocarcinoma JEG-3 cells but not in JAr or human natural killer NK92mi cells. JEG-3, JAr and NK92mi cells
expressed both LILRB1 and KIR2DL4 receptors. The b-actin protein was used as loading control. (B) Immunofluorescent staining (green) showed the
LILRB1 and KIR2DL4 receptors were expressed in the JAr and JEG-3 cells mainly in the cytoplasm and membrane areas. Representative images are
from three sets of individual experiments. (C) Human primary trophoblastic cells stained for HLA-G5, LILRB1 and KIR2DL4 receptors. The nuclei of the
cells were counterstained with DAPI. 100x Magnification.
doi:10.1371/journal.pone.0076023.g002
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Analysis of the role of LILRB1 and KIR2DL4 in mediating
trophoblast function
Trophoblast cells were pre-treated with antibodies against
KIR2DL4 or LILRB1 (in a molar ratio of 5:1 to HLA-G5) for 1
hour and the binding of HLA-G5 onto cells was determined. The
effect of HLA-G5 on invasion of cells pre-treated with antibodies
was also examined.
Data Analysis and Statistics
All data were presented as the mean 6 standard error mean
(SEM). Statistical analysis was performed using one-way ANOVA
or t-test (for data normally distributed) or Kruskal-Wallis ranked
one-way ANOVA (for data with skewed distribution). The p-values
less than 0.05 were considered statistically significant.
Results
Synthesis of the HLA-G5 recombinant protein
The E. coli BL21 cells treated with isopropyl-b-D-thiogalactoside
over-expressed HLA-G5 proteins that were detected in the inclusion
bodies (Figure 1A). The recombinant HLA-G5 proteins extracted
from the inclusion bodies were purified after refolding, resulting in a
single 38 kDa protein band as predicted. The protein was
confirmed to be HLA-G5 by Western blotting and by mass
spectrometry (peptide score was 613) (p,0.001) (Figure 1B and 1C).
HLA-G5 bound to JAr and JEG-3 cells via specific
receptors
Western blot analysis (Figure 2A) and immunostaining (Figure
2B) showed that HLA-G5 protein was expressed in JEG-3 but not
Figure 3. Binding of pre-labeled HLA-G5 on JAr and JEG-3 trophoblastic cells. Fluorescent-labeled HLA-G5 protein (1 mg/mL) was bound to
trophoblastic cells. The percentage of the bound cells was analyzed by flow-cytometry. Treating the JAr and JEG-3 cells with 5A6G7 antibody
significantly reduced the binding signal of HLA-G5 (from 79.0% to 28.3% and from 92.2% to 52.1%, respectively).
doi:10.1371/journal.pone.0076023.g003
HLA-G5 Stimulates Trophoblast Invasion
PLOS ONE | www.plosone.org 5 October 2013 | Volume 8 | Issue 10 | e76023
in JAr or NK92mi cells. The HLA-G5 specific receptors LILRB1
and KIR2DL4 were found in all three cell lines. Similarly, HLA-
G5, LILRB1 and KIR2DL4 proteins were all expressed in the
human primary trophoblasts (Figure 2C).
Flow cytometry analysis of labeled HLA-G5 in the trophoblastic
cell lines showed that HLA-G5 (1 mg/mL) strongly bound to JAr
and JEG-3 cells. HLA-G5 pre-treated with the anti-HLA-G
polyclonal antibody 5A6G7 significantly reduced the binding of
HLA-G5 to the JAr and JEG-3 cells (from 79.0% to 28.3% and
from 92.2% to 52.1%, respectively; p,0.05) compared to the
unstained HLA-G5 control group (Figure 3).
HLA-G5 increased the invasion but not migration of
trophoblasts
HLA-G5 (#1 mg/mL) did not affect the proliferation of JAr and
JEG-3 cells. However, HLA-G5 (10 mg/mL) treatment signifi-
cantly reduced the proliferation of trophoblastic cells (p,0.01)
compared to the untreated controls (Figure S1 in Supporting File
S1). HLA-G5 (1 mg/mL) treatment increased the invasiveness of
JAr cells (p,0.001) (Figure 4A) and HLA-G5 (0.1 or 1 mg/mL)
increased the invasiveness JEG-3 cells (p,0.05) (Figure 4A)
compared to the untreated controls. HLA-G5 treatments also
increased the invasiveness of the primary trophoblasts (p,0.05)
(Figure 4B). On the other hand, the migration rate of the JAr and
JEG-3 cells were unchanged with HLA-G5 treatments (Figure S2
in Supporting File S1).
HLA-G5 altered mRNA transcription and activity of uPA
and MMPs
HLA-G5 treatments increased the mRNA expression and
activities of proteases in both the JAr and JEG-3 cells (Figure 5A
& B). In the JAr cells treated with HLA-G5 (1 mg/mL), the
expression of MMP2 transcript significantly increased (p,0.05),
whereas uPA and MMP9 expressions were unchanged. In the
JEG-3 cells, the expression of MMP2 transcript significantly
increased (p,0.05) with HLA-G5 (0.1 and 1 mg/mL) treatments
and the uPA transcript level also increased (p,0.05) with HLA-G5
(1 mg/mL) treatment. The expression of MMP9 transcript was not
affected.
The activity of uPA was significantly induced with HLA-G5 (0.1
and 1 mg/mL) treatments in both cell lines (p,0.05) (Figure 5C).
In the JAr cells, the activity of MMP9 was significantly induced
with HLA-G5 (1 mg/mL) (p,0.05), whereas the MMP2 activity
was unchanged (Figure S3 in Supporting File S1). In the JEG-3
cells, the MMP2 and MMP9 activities were significantly induced
(p,0.01) with HLA-G5 (1 mg/mL) (Figure 5D). All the data were
presented as percentages relative to the untreated control (Table
S1 in Supporting File S1).
HLA-G5 induced phosphorylation of ERKs in trophoblasts
Treatment with HLA-G5 (1 mg/mL) did not affect the ERK
expression. However, the phosphorylated ERK level was signif-
icantly increased in both the JAr and JEG-3 cells treated with
HLA-G5 (p,0.05) compared to the untreated control (Figure 6A;
Table S2 in Supporting File S1). We used the ERK inhibitors,
U0126 or PD98059, to study whether HLA-G5 stimulated
trophoblastic cell invasion through the ERK pathway. ERK
inhibitors alone had no significant effect on cell invasion, but both
inhibitors abolished the stimulatory effect of HLA-G5 (1 mg/mL)
on the trophoblast invasion (p,0.05) (Figure 6B).
KIR2DL4 and LILRB1 mediated the HLA-G5 induced
trophoblast invasion
Treatment with anti-KIR2DL4 antibody significantly reduced
the binding of HLA-G5 to the JAr and JEG-3 cells (from 87.9% to
48.2% and from 94.9% to 52.6%, respectively; p,0.05) (Figure
7A). Similarly, anti-LILRB1 antibody reduced the HLA-G5
binding to JAr and JEG-3 cells (from 87.9% to 48.5% and from
Figure 4. Effect of HLA-G5 on trophoblast invasiveness. (A) HLA-G5 (1 mg/mL) significantly increased the invasiveness of JAr and JEG-3 cells
(100x Magnification; N= 4, p,0.05) in the trans-well invasion assay. (B) Similarly, HLA-G5 (1 mg/mL) significantly increased the invasiveness of primary
human trophoblasts (100x Magnification; N= 4, p,0.05). All data are presented as the percentage of invasion relative to untreated control groups.
doi:10.1371/journal.pone.0076023.g004
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94.9% to 49.8%, respectively; P,0.05). The antibody treat-
ments abolished the HLA-G5-induced invasiveness of JAr and
JEG-3 cells. The invasiveness of JEG-3 cells was reduced from
236.2% to 98.3% by the anti-KIR2DL4 antibody and reduced
to 96.2% with the anti-LILRB1 antibody. Similar results were
found with JAr cells treated with these antibodies (p,0.05)
(Figure 7B).
Discussion
We demonstrated that HLA-G5 binding to KIR2DL4 and
LILRB1 receptors could stimulate trophoblast invasion by
increasing uPA/MMP levels. This stimulatory effect on the
invasion by HLA-G5 binding to KIR2DL4 and LILRB1 was
mediated via ERK activation. Trophoblast invasion is crucial to
the implantation process. Insufficient invasion leads to preeclamp-
sia, intrauterine growth restriction and spontaneous abortion,
whereas excessive invasion may lead to placenta accreta [11].
HLA-G5 indirectly induces trophoblast invasion by binding to
decidual leukocytes [15,23–25], which produce cytokines such as
IFN-c, TNF-a, IL-1b and IL-2 that favor trophoblast invasion and
placental vascularization [9,16,26]. In addition, HLA-G5 induces
neo-expression and up-regulation of its receptors on immune cells,
enhancing immune responses that favor trophoblast invasion [25].
Trophoblasts also secrete numerous cytokines including IL-1 and
IL-6 that induce cell invasion [27].
In this study, HLA-G5 stimulated the invasiveness of the
HLA-G positive JEG-3 cells and HLA-G negative JAr cells
[17]. Because both JAr and JEG-3 cells were derived from
choriocarcinoma cell lines, we also used human primary
trophoblast from first trimester pregnancy. We found that
HLA-G5 had a stimulatory effect on the invasion of primary
trophoblasts, and a significant effect was observed after longer
incubation.
A previous study reported that HLA-G5 inhibited growth
factor-stimulated trophoblast (SGHPL-4 cell line) invasion, but did
not affect trophoblast invasion in the absence of stimulation [28].
Our present study used a lower concentration of HLA-G, which
could account for the discrepancy between the results of the
reported study (100 U/mL was 100 times our concentration) and
our study. The concentrations of HLA-G (0.1 – 1 mg/mL) used in
our experiments were within the reported serum HLA-G levels
(0.016 – 4 mg/mL) in normal pregnant women [29]. Both the
JEG-3 and the SGHP-4 cell lines express similar levels of HLA-G
(0.4 mg/mL) [28,30]. High concentrations of HLA-G could inhibit
trophoblast proliferation (Figure S1 in Supporting File S1) and
counteract the stimulatory effect of HLA-G on cell invasion.
During the process of invasion, the trophoblast degrades and
remodels the extracellular matrix of the endometrium. The
trophoblast invasion during first trimester is regulated by the
main proteinases, MMP2, MMP9 and uPA [31–32]. MMP2 plays
a predominant role in the initiation of implantation. During weeks
Figure 5. Effect of HLA-G5 on uPA/MMPs expression and activity in trophoblastic cells. Real-time PCR analysis of the uPA and MMPs
(MMP2 and MMP9) transcripts in HLA-G5 treated (A) JAr and (B) JEG-3 cell lines (N = 6). In JAr cells, the expression of MMP2 transcript increased
significantly after treating with HLA-G5 (*, p,0.05), whereas the uPA and MMP9 were unchanged. In JEG-3 cells, the expression of MMP2 and uPA
increased significantly after treating with HLA-G5 (*, p,0.05), whereas MMP9 was unchanged. (C and D) The activity of uPA was significantly induced
with HLA-G5 in both cell lines (N = 4). Similarly, the activities of MMP9 in both cell lines were significantly increased with HLA-G5 (1 mg/mL)
(*, p,0.05), whereas the activities of MMP2 were significantly increased with HLA-G5 (1 mg/mL) only in the JEG-3 cells (**, p,0.01) compared to
untreated controls.
doi:10.1371/journal.pone.0076023.g005
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Figure 6. Effect of HLA-G5 on the modulation of ERK signaling pathways in trophoblast invasion. (A) HLA-G5 treatment significantly
increased phosphorylated ERK expression in JAr and JEG-3 cells within 30 minutes, whereas the expression of total ERK remained mostly constant
(N = 3, p,0.05) compared to untreated controls. (B) Addition of ERK inhibitors (U0126 and PD98059) reduced the stimulatory effect of HLA-G5 (1mg/
mL) on the invasion of JEG-3 and JAr cells in the trans-well invasion assay compared to the control group (N= 3).
doi:10.1371/journal.pone.0076023.g006
HLA-G5 Stimulates Trophoblast Invasion
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5–9 of gestation, MMP9 production increases, which promotes
trophoblast invasion [31]. uPA is involved in trophoblast invasion
and also mediates spiral artery remodeling [33]. HLA-G5
enhanced the expression of these MMPs and uPA transcripts
and increased their activities.
Although numerous factors are known to regulate tropho-
blast invasion through the activation of specific receptors,
downstream signaling pathways such as the mitogen-activated
protein kinase (MAPK) cascade also play an important role
in trophoblast invasion [34–35]. The MAPKs are a large
family of protein kinases (ERKs, SAPK/JNKs and p38)
involved in cell cycle regulation [22,34,36]. Our study
showed that HLA-G5 treatment activated the ERK pathway
via phosphorylation of ERKs. This was further confirmed by
the reversal of the HLA-G5-induced trophoblast invasion in
cells pre-treated with ERK inhibitors, U0126 and PD98059.
This observation is in agreement with other reports on the
role of MAPK/ERK signaling pathways in trophoblast
invasion [22,37–38].
The HLA-G5-induced trophoblast invasion in the JAr
cells, JEG-3 cells and primary trophoblast depends on the
binding of HLA-G5 to the KIR2DL4 and LILRB1
receptors. Blocking these receptors with antibodies reduced
the binding of HLA-G5 to the trophoblast, and abolished
the stimulatory effect of HLA-G5 on trophoblast invasion.
While these results confirm the involvement of the binding
of HLA-G5 to KIR2DL4 and LILRB1, the existence of
other HLA-G5 specific receptors on trophoblasts cannot be
excluded. For example, CD160 is a HLA-G receptor found
in endothelial cells [39], but it has not been reported in
trophoblasts.
Some studies support the finding that decreased HLA-G
production plays a role in the pathophysiology of preeclampsia
by causing a decrease in maternal immune tolerance to invasive
trophoblasts resulting in defective trophoblastic invasion [40]. Yet,
it has been shown that first trimester serum soluble HLA-G1/G5
did not predict high-risk pregnancies in humans [41]. Therefore, a
larger number of cases would be needed in order to determine
whether soluble HLA-G5 could be used for prediction for these
complications.
In sum, our results showed that HLA-G5 induced trophoblast
invasion by increasing uPA and MMPs expression/activity,
which was mediated by binding of HLA-G5 to KIR2DL4 and
LILRB1 receptors and involves the ERK signaling pathway. In
line with this, recent data suggested that the amount of secretory
HLA-G in embryo culture medium is a sensitive and non-
invasive biochemical marker for evaluating embryo quality and
subsequent pregnancies [42]. Understanding the molecular
mechanisms involved in HLA-G5 mediated trophoblast invasion
may allow us to identify new therapeutic approaches for
placental related disease including preeclampsia and placenta
accreta.
Supporting Information
Supporting File S1 Figure S1 Effect of HLA-G5 on
trophoblast proliferation. The proliferation rates of tropho-
blasts were not affected by HLA-G5 (0.1 or 1 mg/mL) treatments.
However, at higher a concentration of HLA-G5 (10 mg/mL), the
proliferation rates of JAr and JEG-3 cells were significantly
reduced compared to the untreated control (N = 8, p,0.01). The
results are presented as the percentage of fluorescence intensity
relative to the untreated group. Figure S2 Effect of HLA-G5 on
trophoblast migration. The migration rates of JAr and JEG-3
trophoblasts were not affected by HLA-G5 (0.1 or 1 mg/mL)
treatments (N = 8). The results are presented as the percentage of
fluorescence intensity relative to the untreated group. Figure S3
Gelatin zymography of MMP2/MMP9 activity on HLA-
G5 treated trophoblastic cells. In JAr cells, the activity of
MMP9 was induced with HLA-G5 (1 mg/mL) treatment (p,0.05),
whereas in the JEG-3 cells, the activities of MMP2 and MMP9
were both induced with HLA-G5 (1 mg/mL) treatment (N = 3,
p,0.01). Table S1 Changes of uPA/MMPs expression and
activity in trophoblast. In JAr cells, the expression of MMP2
increased significantly (p,0.05), whereas the uPA and MMP9
were unchanged after treatment with HLA-G5 (1 mg/mL). In
JEG-3 cells, the expression of MMP2 increased significantly after
HLA-G5 (0.1 and 1 mg/mL) treatments (p,0.05) but MMP9 was
unchanged, and the uPA expression increased significantly with
HLA-G5 (1 mg/mL) (p,0.05). The uPA activities in both cell lines
were significantly induced by HLA-G5 (0.1 and 1 mg/mL)
treatments (N = 4, p,0.05). Gelatin zymographic analysis (N = 3)
of MMP2 and MMP9 activity in JAr cells showed the activity of
MMP9 was significantly induced with HLA-G5 (1 mg/mL)
(p,0.05), whereas in the JEG-3 cells, the activities of MMP2
and MMP9 were both significantly induced with HLA-G5 (1 mg/
mL) (p,0.01). Table S2 ERK phosphorylation in tropho-
blast. The phosphorylated ERK was significantly induced after
HLA-G5 treatment (p,0.05), whereas the expression of ERK
remained mostly unchanged.
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